Sonja Leyrer
27Patents
7h-index
6Co-inventors
58Inventor score
Filing activity: May 14, 2003 → May 2, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7550147B2 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | Emerging Cross-Sectional Technologies | 36 | Expired |
| US8309098B2 | Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs) | Emerging Cross-Sectional Technologies | 18 | Active |
| US7501127B2 | Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara | Emerging Cross-Sectional Technologies | 17 | Active |
| US8021669B2 | Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) | Emerging Cross-Sectional Technologies | 15 | Active |
| US8029800B2 | Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) | Emerging Cross-Sectional Technologies | 9 | Active |
| US8435543B2 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | Emerging Cross-Sectional Technologies | 7 | Active |
| US7964374B2 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | Emerging Cross-Sectional Technologies | 7 | Active |
| US8309326B2 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | Emerging Cross-Sectional Technologies | 7 | Active |
| US8034354B2 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | Emerging Cross-Sectional Technologies | 7 | Active |
| US8414900B2 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | Emerging Cross-Sectional Technologies | 7 | Active |
| US8288125B2 | Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA) | Emerging Cross-Sectional Technologies | 7 | Active |
| US8143054B2 | Fusion protein of HIV regulatory/accessory proteins | Chemistry; Metallurgy | 6 | Active |
| US7338662B2 | Recombinant poxvirus expressing homologous genes inserted into the foxviral genome | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7759116B2 | MVA virus vector expressing dengue NS1 protein | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8197822B2 | Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs) | Emerging Cross-Sectional Technologies | 3 | Active |
| US8198088B2 | Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs) | Emerging Cross-Sectional Technologies | 3 | Active |
| US8741308B2 | Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) | Emerging Cross-Sectional Technologies | 2 | Active |
| US8323661B2 | Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) | Emerging Cross-Sectional Technologies | 2 | Active |
| US8741653B2 | Single recombination system and methods of use | Emerging Cross-Sectional Technologies | 2 | Active |
| US7300658B2 | Recombinant poxvirus comprising at least two compox ATI promoters | Chemistry; Metallurgy | 2 | Expired |
| US8147839B2 | Fusion proteins of HIV regulatory/accessory proteins | Chemistry; Metallurgy | 1 | Active |
| US8137931B2 | Fusion proteins of HIV regulatory/accessory proteins | Chemistry; Metallurgy | 1 | Active |
| US8815501B2 | Flavivirus NS1 subunit vaccine | Emerging Cross-Sectional Technologies | 0 | Active |
| US8389275B2 | Fusion proteins of HIV regulatory/accessory proteins | Chemistry; Metallurgy | 0 | Active |
| US8435535B2 | Fusion proteins of HIV regulatory/accessory proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.